SA
RLAY icon

Sanctuary Advisors’s Relay Therapeutics RLAY Stock Holding History

Sanctuary Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43M Buy
143,816
+1,588
+1% +$14.2K 0.01% 1127
2025
Q4 		$1.2M Buy
+142,228
New +$1.01M 0.01% 1222
2025
Q3 		– Sell
-58,654
Closed -$203K – 2527
2025
Q2 		$203K Buy
+58,654
New +$174K ﹤0.01% 2173

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Sanctuary Advisors's RLAY Position: Q1 2026 in Review

Sanctuary Advisors increased its Relay Therapeutics (RLAY) stake by 1.1% in Q1 2026, buying an estimated $14.2K and bringing the position to 143,816 shares worth $1.43M. The position accounts for 0.01% of the portfolio, ranked #1127.

Sanctuary Advisors first reported a position in RLAY in Q2 2025 and has held it in 3 quarters since. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Sanctuary Advisors held 143,816 shares of Relay Therapeutics worth $1.43M as of Q1 2026.
  • Sanctuary Advisors bought 1,588 Relay Therapeutics shares in Q1 2026, an estimated $14.2K.
  • Relay Therapeutics made up 0.01% of Sanctuary Advisors's portfolio in Q1 2026, its #1127 holding.
  • Sanctuary Advisors first reported a position in Relay Therapeutics in Q2 2025 and has held it in 3 quarters since.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.